Consun Pharmaceutical Group Ltd. held its Annual General Meeting on Thursday, 22 May 2025. All proposed resolutions were approved by shareholders. These included extending the general mandate granted to the Directors to issue, allot, and deal with additional shares of the Company to include shares repurchased under a separate mandate.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.